Neurexis Therapeutics
Biotechnology ResearchColorado, United States2-10 Employees
Neurexis is developing an optimized peptide with demonstrated efficacy and safety in small and large animal models of global cerebral ischemia.
Insights
Gathering insights about Neurexis Therapeutics…
Similar companies to Neurexis Therapeutics
Neurexis Therapeutics Tech Stack
Neurexis Therapeutics uses 8 technology products and services including Statically, WordPress, RSS, and more. Explore Neurexis Therapeutics's tech stack below.
- StaticallyContent Delivery Network
- WordPressContent Management System
- RSSContent Management System
- oEmbedDev Tools
- WooCommerceE-commerce
- iubendaGovernance, Risk And Compliance
- JSON-LDJavascript Frameworks
- jQueryJavascript Libraries
Media & News
Neurexis Therapeutics's Email Address Formats
Neurexis Therapeutics uses at least 1 format(s):
| Neurexis Therapeutics Email Formats | Percentage |
| First.Last@neurexistherapeutics.com | 50% |
| First.Last@neurexistherapeutics.com | 50% |
Frequently Asked Questions
Where is Neurexis Therapeutics's headquarters located?
Neurexis Therapeutics's main headquarters is located at 12635 East Montview Boulevard, Suite 100. The company has employees across 1 continents, including North America. What is Neurexis Therapeutics's official website and social media links?
Neurexis Therapeutics's official website is neurexistherapeutics.com and has social profiles on LinkedInCrunchbase.What is Neurexis Therapeutics's SIC code NAICS code?
Neurexis Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Neurexis Therapeutics have currently?
As of December 2025, Neurexis Therapeutics has approximately 4 employees across 1 continents, including North America. Key team members include Chief Executive Officer | Chair, Board Of Directors | Co-Founder: M. A.Vice President Of Research And Development: R. G.Senior Scientist: N. R.. Explore Neurexis Therapeutics's employee directory with LeadIQ.What industry does Neurexis Therapeutics belong to?
Neurexis Therapeutics operates in the Biotechnology Research industry. What technology does Neurexis Therapeutics use?
Neurexis Therapeutics's tech stack includes StaticallyWordPressRSSoEmbedWooCommerceiubendaJSON-LDjQuery. What is Neurexis Therapeutics's email format?
Neurexis Therapeutics's email format typically follows the pattern of First.Last@neurexistherapeutics.com. Find more Neurexis Therapeutics email formats with LeadIQ. How much funding has Neurexis Therapeutics raised to date?
As of December 2025, Neurexis Therapeutics has raised $496K in funding. The last funding round occurred on Oct 14, 2021 for $496K.
Company Overview
- Headquarters
- 12635 East Montview Boulevard, Suite 100
- Website
- neurexistherapeutics.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Employees
- 2-10
Media & News
Funding & Financials
- $496K
Neurexis Therapeutics has raised a total of $496K of funding over 1 rounds. Their latest funding round was raised on Oct 14, 2021 in the amount of $496Kas a grant.
- $1M$10M
Neurexis Therapeutics's revenue is estimated to be in the range of $1M$10M
Funding & Financials
- $496K
Neurexis Therapeutics has raised a total of $496K of funding over 1 rounds. Their latest funding round was raised on Oct 14, 2021 in the amount of $496Kas a grant.
- $1M$10M
Neurexis Therapeutics's revenue is estimated to be in the range of $1M$10M
Company Leadership
M. A.Chief Executive Officer | Chair, Board Of Directors | Co-Founder
R. G.Vice President Of Research And Development- N. R.Senior Scientist
Employee Directory
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
